iGEN
Visit IGEN World Explore IGEN Expo
EXPLORE UPGRADE PLANS
BREAKING
Inside the rogue ChatGPT hack of Hugging Face: AI agents operate at superhuman speed but make clumsy mistakes Landstar Expects to Emerge a Winner After Supreme Court’s Montgomery Ruling Widens Broker Liability New Senate bill targets 'chameleon carriers' that reopen to escape penalties Werner Enterprises Posts Highest Revenue Per Truck Growth in One-Way Segment in a Decade CMA CGM and Stonepeak Launch United Ports LLC in $2.4 Billion Terminal Joint Venture UPS shift away from Amazon shows bigger payoff Lanesurf: 62% of Loads Get Vetted Carrier Offers Before Brokers Arrive India-China Border Trade Via Lipulekh Resumes Aug 1; China Permits 20 Traders Geopolitics Drives CMA CGM Q2 Profit Surge of 42% as Volumes and Rates Climb Benchmark Diesel Price Rises Third Week as Futures Plunge; Spread Hits Record Inside the rogue ChatGPT hack of Hugging Face: AI agents operate at superhuman speed but make clumsy mistakes Landstar Expects to Emerge a Winner After Supreme Court’s Montgomery Ruling Widens Broker Liability New Senate bill targets 'chameleon carriers' that reopen to escape penalties Werner Enterprises Posts Highest Revenue Per Truck Growth in One-Way Segment in a Decade CMA CGM and Stonepeak Launch United Ports LLC in $2.4 Billion Terminal Joint Venture UPS shift away from Amazon shows bigger payoff Lanesurf: 62% of Loads Get Vetted Carrier Offers Before Brokers Arrive India-China Border Trade Via Lipulekh Resumes Aug 1; China Permits 20 Traders Geopolitics Drives CMA CGM Q2 Profit Surge of 42% as Volumes and Rates Climb Benchmark Diesel Price Rises Third Week as Futures Plunge; Spread Hits Record
Home ›› Manufacturing ›› Mfg Pharma ›› Wegovy Weight Loss Pill Now Available Privately in UK Pharmacies, Offers Needle-Free Alternative

Wegovy Weight Loss Pill Now Available Privately in UK Pharmacies, Offers Needle-Free Alternative

The once-a-day Wegovy weight loss pill, containing semaglutide, is now available to buy privately from High Street and online pharmacies in the UK. It offers an alternative to the injection, with similar effectiveness, but requires strict dosing guidelines including fasting before each dose. Key differences and eligibility criteria are outlined.

iG
iGEN Editorial
July 6, 2026
Wegovy Weight Loss Pill Now Available Privately in UK Pharmacies, Offers Needle-Free Alternative

A once-daily weight loss pill containing semaglutide is now available to buy privately from High Street and online pharmacies in the UK, according to a BBC report. The oral Wegovy tablet, which contains the same active ingredient as the Wegovy weight loss injection, is advised to be used alongside a healthy diet and increased physical activity. It is not yet available on the NHS.

Availability and Eligibility

The pill is available to people with a BMI of 30 and above (generally considered obese) or a BMI of 27-30 (overweight) if they also have certain weight-related health conditions, such as type 2 diabetes or high blood pressure. These criteria are essentially the same as those for the injection. A consultation – either online or face-to-face – is required to ensure the pill is appropriate. Several online and high street pharmacies report they will have stocks soon, with some suggesting signing up to waiting or mailing lists to stay updated.

Pill vs Injection: Key Differences

Both the pill and injection contain semaglutide and work by mimicking the hormone GPL-1 (glucagon-like-peptide-1) , which is released from the intestine after eating. It acts on receptors in the brain that control appetite, making people feel fuller, less hungry, and crave food less. Trials show they are similarly effective, according to the BBC.

Aspect Pill (once-daily) Injection (once-weekly)
Dosing frequency Once a day Once a week
Administration Swallow whole with up to 120ml water Inject into skin
Food/fluid restrictions Must be taken on empty stomach after at least 8 hours fast; no food/drink/other meds for 30 mins after No food restrictions; can be taken any time of day
Storage No refrigeration required Must be stored in fridge
Needle avoidance Suitable for those who don't like needles Requires injection

Dosing and Administration

There are strict guidelines to ensure proper absorption. The pill must be taken:

  • On an empty stomach after not eating for at least eight hours.
  • At least 30 minutes before eating or drinking anything else or taking other tablets.
  • With a sip of up to 120ml of plain water (not fizzy water, coffee, or tea) and swallowed whole.

Ideally, it is taken at the same time every day. If a dose is missed, the advice is to skip that day's dose and resume the scheduled dose the next day.

Dosage progression:

  • Starting dose: 1.5mg once daily for one month.
  • After consultation, the dose generally increases each month until the recommended maximum dose of 25mg once daily.
  • It can take several months to get full benefits, and there is a risk that weight may return after stopping, according to the BBC.

Side Effects

Very common side effects with both pill and injection include stomach problems such as feeling sick, vomiting, constipation, and diarrhoea. With the injection, mild skin redness, itching, or swelling at the injection site may occur. Some people on either form may experience stomach pain, headaches, and tiredness. More rarely, serious complications such as low blood sugar, pancreatitis, or severe allergic reactions can occur. The medication should not be taken by individuals under 18, who are pregnant or breastfeeding, and a doctor should be consulted about other medical conditions or medications.

Implications for the Pharmaceutical Sector

The introduction of an oral formulation of semaglutide expands patient choice and could influence manufacturing demand for tablet versus injectable forms. While the BBC report does not provide production or supply chain details, the availability of Wegovy as a pill in UK pharmacies marks a significant step in weight management options. The once-daily regimen and fasting requirement differentiate it from the weekly injection, potentially affecting patient adherence and market dynamics.


Sources: BBC-Business

Keep Reading

Recommended Stories

Semaglutide therapy market faces Rs 100 crore excess stock after initial rush Manufacturing

Semaglutide therapy market faces Rs 100 crore excess stock after initial rush

The Indian semaglutide therapy market is facing an excess stock of approximately Rs 100 crore, with stockists holding 50-60 days of inventory after a sharp slowdown in May sales. The market had surged following patent expiry in March but growth slowed drastically, leading to a halt in fresh procurement from pharmaceutical companies.

June 22, 2026
TNAU patents high-yield eco-friendly cadambine extraction method from Kadamba tree Manufacturing

TNAU patents high-yield eco-friendly cadambine extraction method from Kadamba tree

Tamil Nadu Agricultural University (TNAU) has secured a patent for a novel method to isolate and quantify cadambine from the Kadamba tree. The process delivers a 93-94% recovery yield while significantly reducing solvent consumption, waste generation, and processing time.

July 9, 2026
WHO-Led PARTNERS Trial Begins Patient Enrolment for Bundibugyo Virus Disease Treatments Manufacturing

WHO-Led PARTNERS Trial Begins Patient Enrolment for Bundibugyo Virus Disease Treatments

The PARTNERS clinical trial, sponsored by WHO, has opened patient enrolment in the Democratic Republic of the Congo to evaluate antiviral therapies MBP134 and remdesivir for Bundibugyo virus disease (BVD). The trial aims to identify the first effective treatments for BVD, which has affected over 1,400 people in the current outbreak.

July 3, 2026
Just About Anyone Can Sell GLP-1s Online Now: Turnkey Telehealth Sparks Market Flood Manufacturing

Just About Anyone Can Sell GLP-1s Online Now: Turnkey Telehealth Sparks Market Flood

The rise of turnkey telehealth services is enabling companies with no medical background—from search platforms like JustAnswer to dating apps like Grindr—to sell GLP-1 drugs online. Infrastructure firms handle software, clinician networks, and compliance, allowing new entrants to launch in as little as three hours. The trend is accelerating rapidly, with one provider reporting a minimum of one new brand launch per day.

July 1, 2026